BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32433469)

  • 21. DNA-Programmed Chemical Synthesis of Polymers and Inorganic Nanomaterials.
    Xu X; Winterwerber P; Ng D; Wu Y
    Top Curr Chem (Cham); 2020 Mar; 378(2):31. PubMed ID: 32146596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An automated curation procedure for addressing chemical errors and inconsistencies in public datasets used in QSAR modelling.
    Mansouri K; Grulke CM; Richard AM; Judson RS; Williams AJ
    SAR QSAR Environ Res; 2016 Nov; 27(11):939-965. PubMed ID: 27885862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format.
    Thomas DG; Gaheen S; Harper SL; Fritts M; Klaessig F; Hahn-Dantona E; Paik D; Pan S; Stafford GA; Freund ET; Klemm JD; Baker NA
    BMC Biotechnol; 2013 Jan; 13():2. PubMed ID: 23311978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research.
    Slenter DN; Kutmon M; Hanspers K; Riutta A; Windsor J; Nunes N; Mélius J; Cirillo E; Coort SL; Digles D; Ehrhart F; Giesbertz P; Kalafati M; Martens M; Miller R; Nishida K; Rieswijk L; Waagmeester A; Eijssen LMT; Evelo CT; Pico AR; Willighagen EL
    Nucleic Acids Res; 2018 Jan; 46(D1):D661-D667. PubMed ID: 29136241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory.
    Vance ME; Kuiken T; Vejerano EP; McGinnis SP; Hochella MF; Rejeski D; Hull MS
    Beilstein J Nanotechnol; 2015; 6():1769-80. PubMed ID: 26425429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accessing Expert-Curated Pharmacological Data in the IUPHAR/BPS Guide to PHARMACOLOGY.
    Sharman JL; Harding SD; Southan C; Faccenda E; Pawson AJ; Davies JA;
    Curr Protoc Bioinformatics; 2018 Mar; 61(1):1.34.1-1.34.46. PubMed ID: 30040201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomaterials as efficient platforms for sensing DNA.
    Vikrant K; Bhardwaj N; Bhardwaj SK; Kim KH; Deep A
    Biomaterials; 2019 Sep; 214():119215. PubMed ID: 31146176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CARLSBAD database: a confederated database of chemical bioactivities.
    Mathias SL; Hines-Kay J; Yang JJ; Zahoransky-Kohalmi G; Bologa CG; Ursu O; Oprea TI
    Database (Oxford); 2013; 2013():bat044. PubMed ID: 23794735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SABIO-RK: an updated resource for manually curated biochemical reaction kinetics.
    Wittig U; Rey M; Weidemann A; Kania R; Müller W
    Nucleic Acids Res; 2018 Jan; 46(D1):D656-D660. PubMed ID: 29092055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology.
    Camon E; Magrane M; Barrell D; Lee V; Dimmer E; Maslen J; Binns D; Harte N; Lopez R; Apweiler R
    Nucleic Acids Res; 2004 Jan; 32(Database issue):D262-6. PubMed ID: 14681408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequenced defined biomolecules for nanomaterial synthesis, functionalization, and assembly.
    Slocik JM; Naik RR
    Curr Opin Biotechnol; 2017 Aug; 46():7-13. PubMed ID: 28088101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curation and analysis of multitargeting agents for polypharmacological modeling.
    Reddy AS; Tan Z; Zhang S
    J Chem Inf Model; 2014 Sep; 54(9):2536-43. PubMed ID: 25133604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An annotated corpus with nanomedicine and pharmacokinetic parameters.
    Lewinski NA; Jimenez I; McInnes BT
    Int J Nanomedicine; 2017; 12():7519-7527. PubMed ID: 29066897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mining clinical attributes of genomic variants through assisted literature curation in Egas.
    Matos S; Campos D; Pinho R; Silva RM; Mort M; Cooper DN; Oliveira JL
    Database (Oxford); 2016; 2016():. PubMed ID: 27278817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative assessment of nanomaterial definitions and safety evaluation considerations.
    Boverhof DR; Bramante CM; Butala JH; Clancy SF; Lafranconi M; West J; Gordon SC
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):137-50. PubMed ID: 26111608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture medium-associated physicochemical insights on the cytotoxicity of carbon nanomaterials.
    Kong H; Wang L; Zhu Y; Huang Q; Fan C
    Chem Res Toxicol; 2015 Mar; 28(3):290-5. PubMed ID: 25580995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.
    Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System.
    Lee GH; Ahn KH; Yu IJ
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protein-nanomaterial interface.
    Asuri P; Bale SS; Karajanagi SS; Kane RS
    Curr Opin Biotechnol; 2006 Dec; 17(6):562-8. PubMed ID: 17015011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine learning-integrated omics for the risk and safety assessment of nanomaterials.
    Ahmad F; Mahmood A; Muhmood T
    Biomater Sci; 2021 Mar; 9(5):1598-1608. PubMed ID: 33443512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.